In the pursuit of faster and more reliable recombinant protein production, transient transfection has emerged as a cornerstone of early biopharmaceutical development. Compared to stable transfection, ...

Increasing demand for adeno-associated virus (AAV) vectors in therapeutic applications has highlighted the need for scalable and efficient methods to produce complete, high-quality AAV particles.

SHANGHAI, Nov. 6, 2024 /PRNewswire/ -- Duoning Biotechnology Group ("Duoning") announced a strategic partnership agreement with Branca Bunús Ltd. ("Branca Bunús"). Under this agreement, the two ...

Duoning Biotechnology Group has partnered with Branca Bunús Ltd. to collaborate on the development, optimization, and application of transfection reagents, with the goal of providing biopharmaceutical ...

Novel Dual-Plasmid Transfection System Improves Titer And Product Quality In AAV Manufacturing Adeno-associated virus (AAV) vectors are a widely-used, versatile, and appealing gene therapy delivery ...

Chinese hamster ovary (CHO) cells have become one of the most popular cell type for recombinant antibody production – for good reason. CHO cells meet several key requirements for industrial scale ...

From discovery to commercialization, the life cycle of biopharmaceuticals is driven by safety, affordability, and timeliness to market. Process optimization holds the key to shortening the development ...

Recombinant protein expression in eukaryotic insect cells is a powerful approach for producing challenging targets. However, due to incompatibility with standard baculoviral platforms and existing low ...

ProteoGenix, a contract research organization specialized in biologics discovery and bioproduction, announces the launch of its XtenCHO TM Transient Expression System. Due to its enhanced plasmid ...